388 related articles for article (PubMed ID: 14987573)
1. Essential biochemistry and physiology of (NT-pro)BNP.
Hall C
Eur J Heart Fail; 2004 Mar; 6(3):257-60. PubMed ID: 14987573
[TBL] [Abstract][Full Text] [Related]
2. NT-ProBNP: the mechanism behind the marker.
Hall C
J Card Fail; 2005 Jun; 11(5 Suppl):S81-3. PubMed ID: 15948107
[TBL] [Abstract][Full Text] [Related]
3. Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus.
Walther T; Stepan H; Pankow K; Gembardt F; Faber R; Schultheiss HP; Siems WE
BJOG; 2004 May; 111(5):452-5. PubMed ID: 15104609
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
5. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
[TBL] [Abstract][Full Text] [Related]
6. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
7. BNP as a biomarker in heart disease.
Vuolteenaho O; Ala-Kopsala M; Ruskoaho H
Adv Clin Chem; 2005; 40():1-36. PubMed ID: 16355919
[TBL] [Abstract][Full Text] [Related]
8. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
[TBL] [Abstract][Full Text] [Related]
9. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation.
Cao H; Xue L; Wu Y; Ma H; Chen L; Wang X; Zhu Q; Dai N; Chen Y
Peptides; 2010 Aug; 31(8):1531-9. PubMed ID: 20434499
[TBL] [Abstract][Full Text] [Related]
12. The clearance of BNP modeled using the NT-proBNP-BNP relationship.
Kroll MH; Srisawasdi P
Biosystems; 2007 Mar; 88(1-2):147-55. PubMed ID: 16860926
[TBL] [Abstract][Full Text] [Related]
13. [Brain natriuretic peptide: physiological, biological and clinical aspects].
Cauliez B; Berthe MC; Lavoinne A
Ann Biol Clin (Paris); 2005; 63(1):15-25. PubMed ID: 15689309
[TBL] [Abstract][Full Text] [Related]
14. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP).
Chenevier-Gobeaux C; Claessens YE; Voyer S; Desmoulins D; Ekindjian OG
Clin Chim Acta; 2005 Nov; 361(1-2):167-75. PubMed ID: 15993397
[TBL] [Abstract][Full Text] [Related]
15. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
Gill D; Seidler T; Troughton RW; Yandle TG; Frampton CM; Richards M; Lainchbury JG; Nicholls G
Clin Sci (Lond); 2004 Feb; 106(2):135-9. PubMed ID: 12974669
[TBL] [Abstract][Full Text] [Related]
16. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
[TBL] [Abstract][Full Text] [Related]
17. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
Koch AM; Rauh M; Zink S; Singer H
Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
Hess G; Runkel S; Zdunek D; Hitzler WE
Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
20. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]